| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000023334 |
| Receipt No. | R000026887 |
| Official scientific title of the study | Combination effect of milk ingredients and the external preparation for skin on physical function in healthy Japanese. |
| Date of disclosure of the study information | 2016/07/30 |
| Last modified on | 2016/12/13 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Combination effect of milk ingredients and the external preparation for skin on physical function in healthy Japanese. | |
| Title of the study (Brief title) | Combination effect of milk ingredients and the external preparation for skin on physical function in healthy Japanese. | |
| Region |
|
|
| Condition | |||
| Condition | Healthy adults | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To elucidate the combination effect of milk ingredients and the external preparation for skinactive gel-cream on physical function in healthy Japanese. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Sense of balance, agility, muscle strength, and motor unit activity at the beginning of the trial, one month later, and two months later of the dairy intake of milk ingredients containing tablets and the application of the external preparation to the skin. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Numbered container method |
| Intervention | ||||
| No. of arms | 2 | |||
| Purpose of intervention | Treatment | |||
| Type of intervention |
|
|||
| Interventions/Control_1 | Dairy intake of milk ingredients (1 g/day) containing tablets for 2 months. Exercise on a treadmill (15 min) twice a week for 2 months. Exercise on a bicycle ergometer (15min) twice a week for 2 months.
Apply the external preparation to the skin in thighs of both legs before the exercise. |
|||
| Interventions/Control_2 | Dairy intake of milk ingredients (1 g/day) containing tablets for 2 months. Exercise on a treadmill (15 min) twice a week for 2 months. Exercise on a bicycle ergometer (15min) twice a week for 2 months.
Apply the external preparation (placebo) to the skin in thighs of both legs before the exercise. |
|||
| Interventions/Control_3 | ||||
| Interventions/Control_4 | ||||
| Interventions/Control_5 | ||||
| Interventions/Control_6 | ||||
| Interventions/Control_7 | ||||
| Interventions/Control_8 | ||||
| Interventions/Control_9 | ||||
| Interventions/Control_10 | ||||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | -A person who hasn't had a motor dysfunction.
-A person who is able to participate in a functional fitness test. -A person who hasn't used a cardiac pacemaker and/or an artificial joint. |
|||
| Key exclusion criteria | -A person who has had severe diseases or the past illness on liver, kidney, heart, lung, digestive organs, blood, endocrine, nerve and metabolic system.
-A person who has had severe damage on the locomotive organs such as fracture, tendon rupture, or muscle strain in the past 1 year. -A person who has had dietary allergy. -A person who has taken a lot of milk products. -A person who has had a habit to do strength training. -A person who has been ordered not to do exercise by a medical doctor. -A person who are not eligible due to medical doctor's judgment. |
|||
| Target sample size | 55 | |||
| Research contact person | |
| Name of lead principal investigator | Noriyasu Ota |
| Organization | Kao Corporation |
| Division name | Biological Science Laboratories |
| Address | 2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN |
| TEL | +81-285-68-7828 |
| ota.noriyasu@kao.co.jp | |
| Public contact | |
| Name of contact person | Satoshi Sugita |
| Organization | Kao Corporation |
| Division name | Biological Science Laboratories |
| Address | 2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN |
| TEL | +81-285-68-7769 |
| Homepage URL | |
| sugita.satoshi@kao.co.jp | |
| Sponsor | |
| Institute | Kao Corporation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kao Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 医療法人北斗会宇都宮東病院(栃木県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026887 |